Archer GT. Erythrophagocytosis. Mod Med Aust 1964;7:55.ArcherGT.Erythrophagocytosis.1964;7:55.Search in Google Scholar
Archer GT. Phagocytosis by human monocytes of red cells coated with antibodies. Vox Sang 1965;10:590–8.ArcherGT.Phagocytosis by human monocytes of red cells coated with antibodies.1965;10:590–8.Search in Google Scholar
Cline MJ, Lehrer RI. Phagocytosis by human monocytes. Blood 1968;32:423.ClineMJ,
LehrerRI.Phagocytosis by human monocytes.1968;32:423.Search in Google Scholar
Stevens JO, Schanfield MS, Braley JF. Detection of clinically signifcant IgG antibodies by an in vitro human peritoneal macrophage phagocytosis assay (abstract). Transfusion 1976;16:523.StevensJOSchanfieldMSBraleyJF.Detection of clinically significant IgG antibodies by an in vitro human peritoneal macrophage phagocytosis assay (abstract).1976;16:523.Search in Google Scholar
Schanfeld MS, Bauman D, Stevens JO. The detection of clinically signifcant “low avidity” erythrocyte alloantibodies by human macrophage assay. Transfusion 1978;10:382.SchanfieldMSBaumanDStevensJO.The detection of clinically significant “low avidity” erythrocyte alloantibodies by human macrophage assay.1978;10:382.Search in Google Scholar
Schanfeld MS, Schoeppner SL, Stevens JO. New approaches to detecting clinically signifcant antibodies in the laboratory. In: Sandler SG, Nusbacher J, Schanfeld MS, Eds. Immunobiology of the erythrocyte. New York: Alan Liss, 1980:305–23.SchanfieldMSSchoeppnerSLStevensJO.New approaches to detecting clinically significant antibodies in the laboratory. In:SandlerSGNusbacherJSchanfieldMSEds..New York:Alan Liss,1980:305–23.Search in Google Scholar
Hunt JS, Beck ML, Hardman JT, Tegtmeier GE, Bayer WI. Characterization of human erythrocyte alloantibodies by IgG subclass and monocyte interaction. Am J Clin Pathol 198 0;74:259 –6 4.HuntJSBeckMLHardmanJTTegtmeierGEBayerWI.Characterization of human erythrocyte alloantibodies by IgG subclass and monocyte interaction.1980;74:259–64.Search in Google Scholar
Hunt JS, Beck ML, Wood GW. Monocyte-mediated erythrocyte destruction: a comparative study of current methods. Transfusion 1981;21:735–8.HuntJSBeckMLWoodGW.Monocyte-mediated erythrocyte destruction: a comparative study of current methods.1981;21:735–8.Search in Google Scholar
Schanfeld MS, Stevens JO, Bauman D. The detection of clinically signifcant erythrocyte alloantibodies using a human mononuclear phagocyte assay. Transfusion 1981;21:571–6.SchanfieldMSStevensJOBaumanD.The detection of clinically significant erythrocyte alloantibodies using a human mononuclear phagocyte assay.1981;21:571–6.Search in Google Scholar
Schoeppner-Esty S, Wahl T, Zawisza J, Mallory D, Davey R. Stimulation of antibody following transfusion of red cells during 51chromium survival studies. Blood 1986;68:302a.Schoeppner-EstySWahlTZawiszaJMalloryDDaveyR.Stimulation of antibody following transfusion of red cells during 51chromium survival studies.1986;68:302a.Search in Google Scholar
Schoeppner-Esty S, Chin J, Mallory D, Davey R. A comparison of the monocyte monolayer (MMA) to the 51chromium red cell survival for determining the clinical signifcance of red cell alloantibodies. Blood 1986;68:302a.Schoeppner-EstySChinJMalloryDDaveyR.A comparison of the monocyte monolayer (MMA) to the 51chromium red cell survival for determining the clinical significance of red cell alloantibodies.1986;68:302a.Search in Google Scholar
Eckrich RJ, Mallory DM, Sandler SG. Correlation of monocyte monolayer assays and posttransfusion survival of Yt(a+) red cells in patients with anti-Yta. Immunohematology 1995;11: 81–4.EckrichRJMalloryDMSandlerSG.Correlation of monocyte monolayer assays and posttransfusion survival of Yt(a+) red cells in patients with anti-Yta.1995;11:81–4.Search in Google Scholar
Byrne PC, Eckrich RJ, Malamut DC, Mallory DM, Sandler SG. Use of the monocyte monolayer assay (MMA) to predict the clinical signifcance of anti-Cra (abstract). Transfusion 1995;35:61S.ByrnePCEckrichRJMalamutDCMalloryDMSandlerSG.Use of the monocyte monolayer assay (MMA) to predict the clinical significance of anti-Cra (abstract).1995;35:61S.Search in Google Scholar
Garratty G. Predicting the clinical signifcance of alloantibodies and determining the in vivo survival of transfused red cells. In: Judd WJ, Barnes A, Eds. Clinical and serologic aspects of transfusion reactions. Arlington, VA: AABB, 1982:91–119.GarrattyG.Predicting the clinical significance of alloantibodies and determining the in vivo survival of transfused red cells. In:JuddWJBarnesAEds..Arlington, VA:AABB,1982:91–119.Search in Google Scholar
Garratty G, Nance S, O’Neill P. Correlation of monocyte monolayer assays and RBC survival in patients with allo-antibodies of questionable clinical signifcance. Transfusion 198 5;2 5:474.GarrattyGNanceSO’NeillP.Correlation of monocyte monolayer assays and RBC survival in patients with alloantibodies of questionable clinical significance.1985;25:474.Search in Google Scholar
Garratty G, Nance S, O’Neill P. Factors that afect interpretation of monocyte monolayer assays. Transfusion 1986;26:570.GarrattyGNanceSO’NeillP.Factors that affect interpretation of monocyte monolayer assays.1986;26:570.Search in Google Scholar
Nance S, Arndt P, Garratty G. Predicting the signifcance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:4 49–52.NanceSArndtPGarrattyG.Predicting the significance of red cell alloantibodies using a monocyte monolayer assay.1987;27:449–52.Search in Google Scholar
Nance SJ, Arndt PA, Garratty G. The efect of fresh serum on monocyte monolayer reactivity. Transfusion 1988;28:398–9.NanceSJArndtPAGarrattyG.The effect of fresh serum on monocyte monolayer reactivity.1988;28:398–9.Search in Google Scholar
Levy GJ, Selset G, McQuiston D, et al. Clinical signifcance of anti-Ytb: report of a case using a 51chromium red cell survival study. Transfusion 1988;28:265–7.LevyGJSelsetGMcQuistonDClinical significance of anti-Ytb: report of a case using a 51chromium red cell survival study.1988;28:265–7.Search in Google Scholar
Garratty G. Predicting the clinical signifcance of red cell antibodies with in vitro cellular assays. Trans Med Rev 1990;4:297–312.GarrattyG.Predicting the clinical significance of red cell antibodies with in vitro cellular assays.1990;4:297–312.Search in Google Scholar
Nance S. Review: measuring red cell survival and determining the clinical signifcance of red cell antibodies. Immunohematology 1995;11:31–8.NanceS.Review: measuring red cell survival and determining the clinical significance of red cell antibodies.1995;11:31–8.Search in Google Scholar
Lucas GF, Hadley SG, Nance SJ, Garratty G. Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test. Transfusion 1993;33:484–7.LucasGFHadleySGNanceSJGarrattyG.Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test.1993;33:484–7.Search in Google Scholar
Nance S, Nelson J, O’Neill P, Garratty G. Correlation of monocyte monolayer assays, maternal antibody titers, and clinical course in hemolytic disease of the newborn (HDN) (abstract). Transfusion 1984;24:415.NanceSNelsonJO’NeillPGarrattyG.Correlation of monocyte monolayer assays, maternal antibody titers, and clinical course in hemolytic disease of the newborn (HDN) (abstract).1984;24:415.Search in Google Scholar
Nance S, Nelson J, Horenstein J, O’Neill P, Garratty G. Predictive value of amniocentesis versus monocyte monolayer assays in pregnant women with Rh antibodies (abstract). Transfusion 1986;26:570.NanceSNelsonJHorensteinJO’NeillPGarrattyG.Predictive value of amniocentesis versus monocyte monolayer assays in pregnant women with Rh antibodies (abstract).1986;26:570.Search in Google Scholar
Nance SJ, Nelson JM, Horenstein J, Amdt PA, Platt LD, Garratty G. Monocyte monolayer assay: an efcient noninvasive technique for predicting the severity of hemolytic disease of the newborn. Am J Clin Pathol 1989;92:89–92.NanceSJNelsonJMHorensteinJAmdtPAPlattLDGarrattyG.Monocyte monolayer assay: an efficient non- invasive technique for predicting the severity of hemolytic disease of the newborn.1989;92:89–92.Search in Google Scholar
Mollison PL. Results of tests with diferent cellular bioassays in relation to severity of RhD haemolytic disease: report from nine collaborating laboratories. Vox Sang 1991;60:225–9.MollisonPL.Results of tests with different cellular bioassays in relation to severity of RhD haemolytic disease: report from nine collaborating laboratories.1991;60:225–9.Search in Google Scholar
Hadley AG, Kumpel BM, Leader KA, Poole GD, Fraser ID. Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn. Br J Haematol 1991;77:221–8.HadleyAGKumpelBMLeaderKAPooleGDFraserID.Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn.1991;77:221–8.Search in Google Scholar
Arndt PA, Garratty G. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical signifcance of blood group alloantibodies. Transfusion 2004;44:1273–81.ArndtPAGarrattyG.A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies.2004;44:1273–81.Search in Google Scholar
Nance SJ, Arndt P. What to do when all RBCs are incompatible: serological aspects. Immunohematology 2004;3:147–60.NanceSJArndtP.What to do when all RBCs are incompatible: serological aspects.2004;3:147–60.Search in Google Scholar
Church A, Mallory D, Kavitsky D, Nance S. Impact of complement in the monocyte monolayer assay (abstract). Transfusion 1997;37(Suppl):27S.ChurchAMalloryDKavitskyDNanceS.Impact of complement in the monocyte monolayer assay (abstract).1997;37(Suppl):27S.Search in Google Scholar
Maurer J, Kavitsky DM, Meny G, Nance S. Monocyte monolayer assay (MMA) to predict clinical signifcance of RBC alloantibodies: an update. Transfusion 2011;51(Suppl):171A.MaurerJKavitskyDMMenyGNanceS.Monocyte monolayer assay (MMA) to predict clinical significance of RBC alloantibodies: an update.2011;51(Suppl):171A.Search in Google Scholar
Keller MA, Nickle P, Mansfeld P, et al. Use of monocyte monolayer assay in a patient with anti-hrS and -Hr. Transfusion 2017;57(S 3) : 3 6 A.KellerMANicklePMansfieldP2017;57(S3):36A.Search in Google Scholar
Nance S. A review of the in vitro methods to predict the clinical signifcance of red cell alloantibodies. Immunohematology 2018;34:11–5.NanceS.A review of the in vitro methods to predict the clinical significance of red cell alloantibodies.2018;34:11–5.Search in Google Scholar
Maurer J, Nance S, Nickle P. Relationship of antibody reactivity strength to reactivity in the monocyte monolayer assay (MMA). Transfusion 2018;58:187A.MaurerJNanceSNickleP.Relationship of antibody reactivity strength to reactivity in the monocyte monolayer assay (MMA).2018;58:187A.Search in Google Scholar
Maurer J, Nance S, Nickle P. Monocyte monolayer assay (MMA) to predict clinical signifcance of alloantibodies: a 22 year review. Transfusion 2018;58:103A.MaurerJNanceSNickleP.Monocyte monolayer assay (MMA) to predict clinical significance of alloantibodies: a 22 year review.2018;58:103A.Search in Google Scholar
Flickinger C. In search of red blood cells for alloimmunized patients with sickle cell disease. Immunohematology 2006;22:136–42.FlickingerC.In search of red blood cells for alloimmunized patients with sickle cell disease.2006;22:136–42.Search in Google Scholar
Nance S, Scharberg EA, Thornton N, Yahalom V, Lomas-Francis C. International rare donor panels: a review. Vox Sang 2016;110:209–18.NanceSScharbergEAThorntonNYahalomVLomas-FrancisC.International rare donor panels: a review.2016;110:209–18.Search in Google Scholar
Seltsam A, Wagner FF, Salama A, et al. Antibodies to high frequency antigens may decrease the quality of transfusion support: an observational study. Transfusion 2003;43:1563–6.SeltsamAWagnerFFSalamaAAntibodies to high frequency antigens may decrease the quality of transfusion support: an observational study.2003;43:1563–6.Search in Google Scholar
Branch DR, Gallagher MT, Mison AP, Sy Siok Hian AL, Petz LD. In vitro determination of red cell alloantibody signifcance using an assay of monocyte-macrophage interaction with sensitized erythrocytes. Br J Haematol 1984;56:19–29.BranchDRGallagherMTMisonAPSy Siok HianALPetzLD.In vitro determination of red cell alloantibody significance using an assay of monocyte-macrophage interaction with sensitized erythrocytes.1984;56:19–29.Search in Google Scholar
Branch DR, Gallagher MT. Correlation of in vivo alloantibody signifcance or insignifcance with an in vitro monocyte-macrophage phagocytosis assay. Br J Haematol 1986;62: 783–5.BranchDRGallagherMT.Correlation of in vivo alloantibody significance or insignificance with an in vitro monocyte- macrophage phagocytosis assay.1986;62:783–5.Search in Google Scholar
Branch DR, Gallagher MT. Red blood cell mononuclear phagocyte assay. Vox Sang 1985;48:323–4.BranchDRGallagherMT.Red blood cell mononuclear phagocyte assay.1985;48:323–4.Search in Google Scholar
Branch DR, Gallagher MT. The importance of CO2 in short-term monocyte-macrophage assays. Transfusion 1985;25: 399–400.BranchDRGallagherMT.The importance of CO2 in short-term monocyte-macrophage assays.1985;25:399–400.Search in Google Scholar
Tong TK, Cen S, Branch DR. The monocyte monolayer assay: past, present and future. Transfus Med Rev 2019;33:24–8.TongTKCenSBranchDRThe monocyte monolayer assay: past, present and future.2019;33:24–8.Search in Google Scholar
Kipkeu BJ, Shyian ML, da Silveira Cavalcante L, et al. Evaluation of the functional properties of cryopreserved bufy coat–derived monocytes for monocyte monolayer assay. Transfusion 2018;58:2027–35.KipkeuBJShyianMLda Silveira CavalcanteLEvaluation of the functional properties of cryopreserved buffy coat–derived monocytes for monocyte monolayer assay.2018;58:2027–35.Search in Google Scholar
Brojer E, Zupanska B, Michalewaks B. Adherence to human monocytes of red cells from autoimmune haemolytic anaemia and red cells sensitized with alloantibodies. Haematologia (Budap) 1982;15:135–45.BrojerEZupanskaBMichalewaksBAdherence to human monocytes of red cells from autoimmune haemolytic anaemia and red cells sensitized with alloantibodies.(Budap)1982;15:135–45.Search in Google Scholar
Zupanska B, Thompson E, Brojer E, Merry AH. Phagocytosis of erythrocytes sensitized with known amounts of IgG1 and IgG3 anti-Rh antibodies. Vox Sang 1987;53:96–101.ZupańskaBThompsonEBrojerEMerryAHPhagocytosis of erythrocytes sensitized with known amounts of IgG1 and IgG3 anti-Rh antibodies.1987;53:96–101.Search in Google Scholar
Zupanska B, Brojer E, Richards Y, Lenkiewicz B, Seyfried H, Howell P. Serological and Immunological characteristics of maternal anti-Rh(D) antibodies in predicting severity of haemolytic disease of the newborn. Vox Sang 1989;56:247–53.ZupanskaBBrojerERichardsYLenkiewiczBSeyfriedHHowellPSerological and Immunological characteristics of maternal anti-Rh(D) antibodies in predicting severity of haemolytic disease of the newborn.1989;56:247–53.Search in Google Scholar
Zupanska B, Brojer E, McIntosh J, Seyfried H, Howell P. Correlation of monocyte-monolayer assay results, number of erythrocyte-bound IgG molecules, and IgG subclass composition in the study of red cell alloantibodies other than D. Vox Sang 1990;58:276–80.ZupanskaBBrojerEMcIntoshJSeyfriedHHowellPCorrelation of monocyte-monolayer assay results, number of erythrocyte-bound IgG molecules, and IgG subclass composition in the study of red cell alloantibodies other than D.1990;58:276–80.Search in Google Scholar
Zupanska B, Gronkowska A, Zimeski M. Comparison of activity of peripheral monocytes and splenic macrophages in the monocyte monolayer assay. Vox Sang 1995;68:241–2.ZupanskaBGronkowskaAZimeskiMComparison of activity of peripheral monocytes and splenic macrophages in the monocyte monolayer assay.1995;68:241–2.Search in Google Scholar
Zupanska B. Assays to predict the clinical signifcance of blood group antibodies. Curr Opin Hematol 1998;5:412–6.ZupanskaBAssays to predict the clinical significance of blood group antibodies.1998;5:412–6.Search in Google Scholar
Baldwin ML, Ness PM, Barrasso C, et al. In vivo studies of the long-term 51Cr red cell survival of serologically incompatible red cell units. Transfusion 1985;25:34–8.BaldwinMLNessPMBarrassoCIn vivo studies of the long-term 51Cr red cell survival of serologically incompatible red cell units.1985;25:34–8.Search in Google Scholar
Wren MR, Issitt PD. The monocyte monolayer assay and in vivo antibody activity (abstract). Transfusion 1986;26:548.WrenMRIssittPDThe monocyte monolayer assay and in vivo antibody activity (abstract).1986;26:548.Search in Google Scholar
Issitt PD, Gutgsell NS, Hervis L. Some stored antibodies give unreliable results in the monocyte monolayer assay. Transfusion 1988;28:399–400.IssittPDGutgsellNSHervisLSome stored antibodies give unreliable results in the monocyte monolayer assay.1988;28:399–400.Search in Google Scholar
Gutgsell NS, Issitt LA, Issitt PD. Transfusion of antigen-positive, serologically-incompatible blood in immunized patients, based solely on the results of a monocyte monolayer assay (MMA) (abstract). Transfusion 1988;28:32S.GutgsellNSIssittLAIssittPDTransfusion of antigen- positive, serologically-incompatible blood in immunized patients, based solely on the results of a monocyte monolayer assay (MMA) (abstract).1988;28:32S.Search in Google Scholar
Fabron A Jr, Baleotti W Jr, de Mello AB, et al. Application of noninvasive phagocytic cellular assays using autologous monocytes to assess red cell alloantibodies in sickle cell patients. Transfus Apher Sci 2004;31:29–35.FabronAJrBaleottiWJrde MelloABApplication of noninvasive phagocytic cellular assays using autologous monocytes to assess red cell alloantibodies in sickle cell patients.2004;31:29–35.Search in Google Scholar
Noumsi GT, Billingsley KL, Moulds JM. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay. Transfus Med 2015;25:92–100.NoumsiGTBillingsleyKLMouldsJMSuccessful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay.2015;25:92–100.Search in Google Scholar
El-sayed HAN, Abdollah MRA, Raafat SN, Ragab D. Monocyte monolayer assay in pre-transfusion testing: a magic key in transfusing patients with recurrent bad cross-match due to alloimmunization. J Immunol Methods 2021;492:112968.El-sayedHANAbdollahMRARaafatSNRagabDMonocyte monolayer assay in pre-transfusion testing: a magic key in transfusing patients with recurrent bad cross-match due to alloimmunization.2021;492:112968.Search in Google Scholar
Bromilow IM, Duguid JK. Monocyte monolayer assay, autoanalyser values, and haemolytic disease of the newborn (letter). Br J Haematol 1991;78:588.BromilowIMDuguidJKMonocyte monolayer assay, autoanalyser values, and haemolytic disease of the newborn (letter).1991;78:588.Search in Google Scholar
Brown SJ, Perkins JT, Sosler SD, Hesketh D, Moise KJ. The monocyte-monolayer assay does not predict severity of hemolytic disease of the newborn (abstract). Transfusion 1991;31(Suppl):53S.BrownSJPerkinsJTSoslerSDHeskethDMoiseKJThe monocyte-monolayer assay does not predict severity of hemolytic disease of the newborn (abstract).1991;31(Suppl):53S.Search in Google Scholar
Balola AHA, Mayer B, Bartolmäs T, Salama A. A fuorometric erythrophagocytosis assay using diferentiated monocytic THP-1 cells to assess the clinical signifcance of antibodies to red blood cells. Vox Sang 2021;116:1106–16.BalolaAHAMayerBBartolmäsTSalamaAA fluorometric erythrophagocytosis assay using differentiated monocytic THP-1 cells to assess the clinical significance of antibodies to red blood cells.2021;116:1106–16.Search in Google Scholar
Nance S, Scandone P, Fassl L, et al. Monocyte monolayer assay (MMA) results are afected by transfusion of incompatible red cells (abstract). Transfusion 1997;37(Suppl):37S.NanceSScandonePFasslLMonocyte monolayer assay (MMA) results are affected by transfusion of incompatible red cells (abstract).1997;37(Suppl):37S.Search in Google Scholar
Branch DR, Sandhu G, Raos M. Monocyte monolayer predictions of clinical outcome for serologically incompatible red blood cells is all about timing. Transfusion 2021;61: 2516–7.BranchDRSandhuGRaosMMonocyte monolayer predictions of clinical outcome for serologically incompatible red blood cells is all about timing.2021;61:2516–7.Search in Google Scholar
Nance S. Optimizing the use of limited rare red cells for hematopoietic cell transplant recipients. Transfusion 2007;47: 75 4 –7.NanceSOptimizing the use of limited rare red cells for hematopoietic cell transplant recipients.2007;47:754–7.Search in Google Scholar
Garratty G. Advances in red blood cell Immunology 1960 to 2009. Transfusion 2010;50:526–35.GarrattyGAdvances in red blood cell Immunology 1960 to 2009.2010;50:526–35.Search in Google Scholar
Meny G. Review: transfusing incompatible RBCs: clinical aspects. Immunohematology 2004;20:161–6.MenyGReview: transfusing incompatible RBCs: clinical aspects.2004;20:161–6.Search in Google Scholar